Investment Plan for Europe: EIB grants financing to Apeiron
Commercial & Investment Banking Monday, August 28th, 2017The European Investment Bank (EIB) will provide financing of EUR 25 million to the Austrian biotech company Apeiron Biologics AG (Apeiron).